Literature DB >> 27554969

Loss of C/EBPδ enhances IR-induced cell death by promoting oxidative stress and mitochondrial dysfunction.

Sudip Banerjee1, Nukhet Aykin-Burns1, Kimberly J Krager1, Sumit K Shah1, Stepan B Melnyk2, Martin Hauer-Jensen3, Snehalata A Pawar4.   

Abstract

Exposure of cells to ionizing radiation (IR) generates reactive oxygen species (ROS). This results in increased oxidative stress and DNA double strand breaks (DSBs) which are the two underlying mechanisms by which IR causes cell/tissue injury. Cells that are deficient or impaired in the cellular antioxidant response are susceptible to IR-induced apoptosis. The transcription factor CCAAT enhancer binding protein delta (Cebpd, C/EBPδ) has been implicated in the regulation of oxidative stress, DNA damage response, genomic stability and inflammation. We previously reported that Cebpd-deficient mice are sensitive to IR and display intestinal and hematopoietic injury, however the underlying mechanism is not known. In this study, we investigated whether an impaired ability to detoxify IR-induced ROS was the underlying cause of the increased radiosensitivity of Cebpd-deficient cells. We found that Cebpd-knockout (KO) mouse embryonic fibroblasts (MEFs) expressed elevated levels of ROS, both at basal levels and after exposure to gamma radiation which correlated with increased apoptosis, and decreased clonogenic survival. Pre-treatment of wild type (WT) and KO MEFs with polyethylene glycol-conjugated Cu-Zn superoxide dismutase (PEG-SOD) and catalase (PEG-CAT) combination prior to irradiation showed a partial rescue of clonogenic survival, thus demonstrating a role for increased intracellular oxidants in promoting IR-induced cell death. Analysis of mitochondrial bioenergetics revealed that irradiated KO MEFs showed significant reductions in basal, adenosine triphosphate (ATP)-linked, maximal respiration and reserved respiratory capacity and decrease in intracellular ATP levels compared to WT MEFs indicating they display mitochondrial dysfunction. KO MEFs expressed significantly lower levels of the cellular antioxidant glutathione (GSH) and its precursor- cysteine as well as methionine. In addition to its antioxidant function, GSH plays an important role in detoxification of lipid peroxidation products such as 4-hydroxynonenal (4-HNE). The reduced GSH levels observed in KO MEFs correlated with elevated levels of 4-HNE protein adducts in irradiated KO MEFs compared to respective WT MEFs. We further showed that pre-treatment with the GSH precursor, N-acetyl L-cysteine (NAC) prior to irradiation showed a significant reduction of IR-induced cell death and increases in GSH levels, which contributed to the overall increase in clonogenic survival of KO MEFs. In contrast, pre-treatment with the GSH synthesis inhibitor- buthionine sulfoximine (BSO) further reduced the clonogenic survival of irradiated KO MEFs. This study demonstrates a novel role for C/EBPδ in protection from basal as well as IR-induced oxidative stress and mitochondrial dysfunction thus promoting post-radiation survival.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CCAAT enhancer binding protein delta; Glutathione; Ionizing radiation; Mitochondrial dysfunction; Oxidative stress; Reactive oxygen species

Mesh:

Substances:

Year:  2016        PMID: 27554969      PMCID: PMC5673253          DOI: 10.1016/j.freeradbiomed.2016.08.022

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  59 in total

1.  Role of antioxidant enzymes on ionizing radiation resistance.

Authors:  J Sun; Y Chen; M Li; Z Ge
Journal:  Free Radic Biol Med       Date:  1998-03-01       Impact factor: 7.376

2.  Sensitivity to low-dose/low-LET ionizing radiation in mammalian cells harboring mutations in succinate dehydrogenase subunit C is governed by mitochondria-derived reactive oxygen species.

Authors:  Nukhet Aykin-Burns; Benjamin G Slane; Annie T Y Liu; Kjerstin M Owens; Malinda S O'Malley; Brian J Smith; Frederick E Domann; Douglas R Spitz
Journal:  Radiat Res       Date:  2010-11-17       Impact factor: 2.841

3.  Transcriptional up-regulation of SOD1 by CEBPD: a potential target for cisplatin resistant human urothelial carcinoma cells.

Authors:  Tzyh-Chyuan Hour; Yan-Liang Lai; Ching-I Kuan; Chen-Kung Chou; Ju-Ming Wang; Huang-Yao Tu; Huei-Ting Hu; Chang-Shen Lin; Wen-Jeng Wu; Yeong-Shiau Pu; Esta Sterneck; A-Mei Huang
Journal:  Biochem Pharmacol       Date:  2010-04-10       Impact factor: 5.858

Review 4.  Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth.

Authors:  Jacek Zielonka; B Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

5.  A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection.

Authors:  S Melnyk; M Pogribna; I Pogribny; R J Hine; S J James
Journal:  J Nutr Biochem       Date:  1999-08       Impact factor: 6.048

6.  Elevated Cu/Zn-SOD exacerbates radiation sensitivity and hematopoietic abnormalities of Atm-deficient mice.

Authors:  Y Peter; G Rotman; J Lotem; A Elson; Y Shiloh; Y Groner
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

Review 7.  Interleukins in glioblastoma pathophysiology: implications for therapy.

Authors:  Y T Yeung; K L McDonald; T Grewal; L Munoz
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

8.  Characterization of transgenic Gfrp knock-in mice: implications for tetrahydrobiopterin in modulation of normal tissue radiation responses.

Authors:  Rupak Pathak; Snehalata A Pawar; Qiang Fu; Prem K Gupta; Maaike Berbée; Sarita Garg; Vijayalakshmi Sridharan; Wenze Wang; Prabath G Biju; Kimberly J Krager; Marjan Boerma; Sanchita P Ghosh; Amrita K Cheema; Howard P Hendrickson; Nukhet Aykin-Burns; Martin Hauer-Jensen
Journal:  Antioxid Redox Signal       Date:  2013-05-03       Impact factor: 8.401

9.  Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability.

Authors:  A-Mei Huang; Cristina Montagna; Shikha Sharan; Yajun Ni; Thomas Ried; Esta Sterneck
Journal:  Oncogene       Date:  2004-02-26       Impact factor: 9.867

10.  C/EBPδ deficiency sensitizes mice to ionizing radiation-induced hematopoietic and intestinal injury.

Authors:  Snehalata A Pawar; Lijian Shao; Jianhui Chang; Wenze Wang; Rupak Pathak; Xiaoyan Zhu; Junru Wang; Howard Hendrickson; Marjan Boerma; Esta Sterneck; Daohong Zhou; Martin Hauer-Jensen
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

View more
  20 in total

1.  Metformin mitigates gastrointestinal radiotoxicity and radiosensitises P53 mutation colorectal tumours via optimising autophagy.

Authors:  Long Chen; Fengying Liao; Zhongyong Jiang; Chi Zhang; Ziwen Wang; Peng Luo; Qingzhi Jiang; Jie Wu; Qing Wang; Min Luo; Xueru Li; Yu Leng; Le Ma; Gufang Shen; Zelin Chen; Yu Wang; Xu Tan; Yibo Gan; Dengqun Liu; Yunsheng Liu; Chunmeng Shi
Journal:  Br J Pharmacol       Date:  2020-07-08       Impact factor: 8.739

Review 2.  Protection of the hematopoietic system against radiation-induced damage: drugs, mechanisms, and developments.

Authors:  Yuanyun Wei; Yaqi Gong; Shuang Wei; Yonglin Chen; Jian Cui; Xiang Lin; Yueqiu Yu; Hongxia Yan; Hui Qin; Lan Yi
Journal:  Arch Pharm Res       Date:  2022-08-11       Impact factor: 6.010

3.  Gpx3 and Egr1 Are Involved in Regulating the Differentiation Fate of Cardiac Fibroblasts under Pressure Overload.

Authors:  Guoxing Li; Yuhong Qin; Zhe Cheng; Xiaocheng Cheng; Ruiyu Wang; Xuexiu Luo; Yipin Zhao; Dongying Zhang; Gang Li
Journal:  Oxid Med Cell Longev       Date:  2022-06-28       Impact factor: 7.310

4.  Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD.

Authors:  Xiaotian Sun; Parvaneh Jefferson; Qing Zhou; James M Angelastro; Lloyd A Greene
Journal:  Mol Cancer Res       Date:  2019-11-01       Impact factor: 5.852

5.  Radiation-induced bystander effects impair transplanted human hematopoietic stem cells via oxidative DNA damage.

Authors:  Linping Hu; Xiuxiu Yin; Yawen Zhang; Aiming Pang; Xiaowei Xie; Shangda Yang; Caiying Zhu; Yapu Li; Biao Zhang; Yaojin Huang; Yunhong Tian; Mei Wang; Wenbin Cao; Shulian Chen; Yawei Zheng; Shihui Ma; Fang Dong; Sha Hao; Sizhou Feng; Yongxin Ru; Hui Cheng; Erlie Jiang; Tao Cheng
Journal:  Blood       Date:  2021-06-17       Impact factor: 22.113

6.  The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma.

Authors:  Jeong Hyun Cho; Hyo-Ji Lee; Hyun-Jeong Ko; Byung-Il Yoon; Jongseon Choe; Keun-Cheol Kim; Tae-Wook Hahn; Jeong A Han; Sun Shim Choi; Young Mee Jung; Kee-Ho Lee; Yun-Sil Lee; Yu-Jin Jung
Journal:  Oncotarget       Date:  2017-04-11

7.  The Protective Roles of ROS-Mediated Mitophagy on 125I Seeds Radiation Induced Cell Death in HCT116 Cells.

Authors:  Lelin Hu; Hao Wang; Li Huang; Yong Zhao; Junjie Wang
Journal:  Oxid Med Cell Longev       Date:  2016-12-29       Impact factor: 6.543

8.  Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer Agents.

Authors:  Qing Zhou; Xiotian Sun; Nicolas Pasquier; Parvaneh Jefferson; Trang T T Nguyen; Markus D Siegelin; James M Angelastro; Lloyd A Greene
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

9.  Whole brain irradiation in mice causes long-term impairment in astrocytic calcium signaling but preserves astrocyte-astrocyte coupling.

Authors:  Adam Institoris; Ciaran Murphy-Royal; Stefano Tarantini; Andriy Yabluchanskiy; Jordan N Haidey; Anna Csiszar; Zoltan Ungvari; Grant R Gordon
Journal:  Geroscience       Date:  2020-10-22       Impact factor: 7.581

10.  Cebpd Is Essential for Gamma-Tocotrienol Mediated Protection against Radiation-Induced Hematopoietic and Intestinal Injury.

Authors:  Sudip Banerjee; Sumit K Shah; Stepan B Melnyk; Rupak Pathak; Martin Hauer-Jensen; Snehalata A Pawar
Journal:  Antioxidants (Basel)       Date:  2018-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.